Contracts › W81XWH22C0040
W81XWH22C0040: R&D Dha Phase Ii Sbir Months 1-23 for Project Titled, "Novel Biologic Countermeasure for Acute Radiation Syndrome".
Awarded to Technology Holding Llc by Defense Health Agency.
$3.0Mobligated
$3.0Mpotential value
20 October 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81XWH22C0040 |
|---|---|
| Awardee | Technology Holding Llc |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | UT |
| Offers received | 1 |
| Period of performance | 21 June 2022 to 20 October 2026 |
| Potential end | 20 October 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record